Clinical Trial Update: Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH [Phase 2]

View source ↗

Summary

A Phase 2, placebo-controlled, double-blind trial evaluating the safety and efficacy of SDX in idiopathic hypersomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypersomnia

Drugs mentioned

• SDX

Snippet

Sponsor: Zevra Therapeutics | Conditions: Idiopathic Hypersomnia | Phase 2 | Status: COMPLETED